Strategic Partnerships Veritas actively pursues international collaborations to expand radiation shielding installations, evidenced by partnerships with Interkel Group in Lagos and NorthStar Medical Radioisotopes for radiopharmaceutical facility shielding. Target potential: global hospitals, radiopharma manufacturers, and regional integration partners seeking turnkey shielding solutions.

Turnkey Solutions The company positions itself as a single source for design, production, and installation of pre-engineered radiation shielded facilities. Sales opportunities exist in hospitals expanding radiotherapy centers, imaging suites, or manufacturing radiopharmaceuticals where comprehensive shielding packages reduce vendor coordination risk.

Growth Segments Recent expansions in industrial radiation protection for radiopharmaceutical manufacturing indicate diversification beyond clinical care. Address: industrial sectors and contract manufacturers needing compliant, efficient shielding to support scalable production of isotopes and radiopharmaceuticals.

Global Footprint Headquartered in the US with international project references suggests capability to service global customers. Prioritize multi-region bids and cross-border projects, leveraging VeriShield and SmartDoor systems to differentiate on safety, efficiency, and patient-centric environments.

Market Readiness The company’s growth-oriented revenue range and modest funding signal potential for scale. Engage with executives on strategic collaborations, co-development of modular shielding packages, and financing options to accelerate large-scale installations in hospitals and manufacturing facilities.